Skip to main content
Clinical Trials/NCT01422538
NCT01422538
Completed
N/A

Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck Following Sculptra® Treatment

Ulthera, Inc1 site in 1 country30 target enrollmentMay 2011

Overview

Phase
N/A
Intervention
Ulthera® System
Conditions
Skin Laxity
Sponsor
Ulthera, Inc
Enrollment
30
Locations
1
Primary Endpoint
Lifting and Tightening of Skin as Determined by Masked Assessment of Pre- and Post-treatment Photographs.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This clinical trial will evaluate clinical outcomes associated with the non-invasive Ultherapy™ treatment to improve skin laxity and tightening following a Sculptra® treatment.

Detailed Description

This study is a prospective,single-center, randomized clinical trial. Up to thirty (30) subjects will be treated. Enrolled subjects will be assigned to one of three (3) groups. Up to 10 subjects per group.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
September 2012
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female, aged 35 to 60 years.
  • Subject in good health.
  • Skin laxity in the lower face and neck.
  • Grade 1 and 2 on the Knize Scale

Exclusion Criteria

  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Severe solar elastosis.
  • Excessive subcutaneous fat in the face and neck.
  • Excessive skin laxity on the face and neck.
  • No scarring in areas to be treated.
  • Any open facial wounds or lesions.
  • Acne on the face.
  • Patients who have a history with keloid formation or hypertropic scarring
  • Patients who have a hypersensitivity to injectable poly-L-lactic acid
  • Presence of a metal stent or implant in the facial area to be treated.

Arms & Interventions

Group A

Subjects will receive Ulthera® System alone.

Intervention: Ulthera® System

Group B

Sculptra® only

Intervention: Sculptra®

Group C

Sculptra® treatment followed by Ultherapy™ treatment

Intervention: Sculptra® treatment followed by Ultherapy™ treatment

Outcomes

Primary Outcomes

Lifting and Tightening of Skin as Determined by Masked Assessment of Pre- and Post-treatment Photographs.

Time Frame: 90 days post-treatment

Three masked assessors reviewed pre- and 90 days post-treatment photos from 29 subjects who returned for their 90-day follow-up visit, assessing for improvement in skin laxity at 90 days post-treatment compared to baseline, i.e., lifted and tightened skin in the areas treated with the assigned study treatment based on the assigned study arm.

Secondary Outcomes

  • Overall Aesthetic Improvement at 180 Days Post-treatment(180 days post-treatment)
  • Subject Satisfaction at 180 Days Post-treatment(180 days post-treatment)
  • Overall Aesthetic Improvement at 90 Days Post-treatment(90 days post-treatment.)
  • Subject Satisfaction at 90 Days Post-treatment(90 days post-treatment.)

Study Sites (1)

Loading locations...

Similar Trials